We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,062 results
  1. Alternative activation of macrophages by prostacyclin synthase ameliorates alcohol induced liver injury

    Alcoholic liver disease (ALD) is a major cause of chronic liver disease worldwide. Macrophages exhibit different functional states and are classified...

    Xue-yin Pan, Ling Wang, ... Jun Li in Laboratory Investigation
    Article Open access 10 June 2021
  2. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension

    Background

    Pulmonary arterial hypertension (PAH), Group 1 pulmonary hypertension (PH), is a type of pulmonary vascular disease characterized by...

    Cheng Zeng, **g Liu, ... Yuhu He in Respiratory Research
    Article Open access 01 November 2023
  3. In vitro effect of relaxin in the rat corpus cavernosum under hyperglycemic and normoglycemic conditions

    Relaxin, an endogenous peptide hormone, elicits vascular relaxation by its direct effect or by modulating the endothelium-dependent relaxation...

    Selin Acar-Sahan, Ozge Guner, ... Nergiz Durmus in International Journal of Impotence Research
    Article 12 December 2022
  4. Atraumatisches Knochenmarködem des Kniegelenks

    Bone marrow edema (BME) represents a magnetic resonance imaging (MRI) phenomenon characterized by hypointensity on T1-weighted images and...

    Lukas N. MĂĽnch, Jakob Ackermann, ... Elmar Herbst in Arthroskopie
    Article Open access 04 April 2024
  5. Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?

    Pulmonary arterial hypertension (PAH) is a progressive disease that despite advances in therapy is associated with a 7-year survival of approximately...

    Ayedh K. Alamri, Christy L. Ma, John J. Ryan in Drugs
    Article 05 April 2023
  6. Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension

    Background

    Pulmonary arterial hypertension (PAH) is a severe, life-threatening disorder despite the availability of specific drug therapy. A lack of...

    Mustafa Yildiz, Serkan Kahraman, ... Ali K. Kalkan in Herz
    Article 10 June 2021
  7. Divergent roles of prostacyclin and PGE2 in human tendinopathy

    Background

    Tendon disease is a significant global healthcare burden whereby patients experience pain and disability; however, the mechanisms that...

    Filip Bergqvist, Andrew J. Carr, ... Stephanie G. Dakin in Arthritis Research & Therapy
    Article Open access 13 March 2019
  8. Molecular docking prediction and in vitro studies elucidate anti-inflammatory effect of Garcinia extract against inducible nitric oxide synthase and cyclooxygenase-2 targets

    Background

    Garcinia is a tropical plant that has been traditionally used in medicinal folklore for its potential antioxidant, antibacterial,...

    Anuradha Kalita, Manas Das, ... Momita Rani Baro in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 03 March 2022
  9. The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD

    Interstitial lung diseases (ILD) encompasses a heterogeneous group of parenchymal lung diseases characterized by variable amounts of inflammation and...

    Martin Kolb, Stylianos E. Orfanos, ... Steven D. Nathan in Advances in Therapy
    Article Open access 03 July 2022
  10. Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation

    Background

    Pulmonary hypertension is a common and serious complication of chronic obstructive pulmonary disease (COPD). Studies suggest that cigarette...

    Abdullah A. Alqarni, Oliver J. Brand, ... Linhua Pang in Respiratory Research
    Article Open access 28 May 2022
  11. Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension—the Importance of a Mechanistic, Personalized Approach

    Resistant hypertension (RHT) is characterized by persistently high blood pressure (BP) levels above the widely recommended therapeutic targets of...

    Giulia Nardoianni, Barbara Pala, ... Giuliano Tocci in High Blood Pressure & Cardiovascular Prevention
    Article Open access 01 March 2024
  12. Pulmonary Complications of the Liver

    Purpose of Review

    Hepatic hydrothorax (HH), hepatopulmonary syndrome (HPS), and portopulmonary hypertension (PoPH) are the most common complications...

    Constanza Delfina Sabate, Maurizio Camere, ... Manuel Mendizabal in Current Hepatology Reports
    Article 08 February 2024
  13. Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications

    Pulmonary arterial hypertension is characterized by elevated blood pressure and pathological changes in the pulmonary arterioles, leading to the...

    Maria Eugenia Novara, Enrica Di Martino, ... Alessio Provenzani in Drugs in R&D
    Article Open access 22 March 2024
  14. The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective

    Coronary microvascular dysfunction (CMD) refers to a group of disorders affecting the structure and function of coronary microcirculation and is...

    Houyong Zhu, Hanxin Wang, ... **yu Huang in Advances in Therapy
    Article 24 October 2022
  15. New progress in diagnosis and treatment of pulmonary arterial hypertension

    Pulmonary arterial hypertension (PAH) is a progressive disease. Although great progress has been made in its diagnosis and treatment in recent years,...

    Zai-qiang Zhang, Sheng-kui Zhu, ... Jia-wang Ding in Journal of Cardiothoracic Surgery
    Article Open access 29 August 2022
  16. Genetics of ischemic stroke functional outcome

    Ischemic stroke, which accounts for 87% of cerebrovascular accidents, is responsible for massive global burden both in terms of economic cost and...

    Troy P. Carnwath, Stacie L. Demel, Charles J. Prestigiacomo in Journal of Neurology
    Article Open access 19 March 2024
  17. Oridonin attenuates low shear stress-induced endothelial cell dysfunction and oxidative stress by activating the nuclear factor erythroid 2-related factor 2 pathway

    Background

    Atherosclerosis (AS) is the primary cause of cardiovascular disease and the incidence is extremely common; however, there are currently few...

    Zhipeng Chen, Heqian Liu, ... Tong Qiao in BMC Complementary Medicine and Therapies
    Article Open access 07 July 2022
  18. Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice

    Background

    Neutral cholesterol ester hydrolase 1 (NCEH1) plays a critical role in the regulation of cholesterol ester metabolism. Deficiency of NCHE1...

    Hai-Jian Sun, Zhang-Rong Ni, ... Qing-Bo Lu in Cardiovascular Diabetology
    Article Open access 25 April 2024
  19. Mechanistic study on vasodilatory and antihypertensive effects of hesperetin: ex vivo and in vivo approaches

    Hesperetin is one of the prominent flavonoids found in citrus fruit. Several research studies have reported that hesperetin can promote vasodilation...

    Wan Yin Tew, Chu Shan Tan, ... Mun Fei Yam in Hypertension Research
    Article 24 June 2024
  20. Vascular Metabolic Mechanisms of Pulmonary Hypertension

    Pulmonary hypertension (PH) is a severe and progressive disease characterized by increased pulmonary vascular resistance leading to right heart...

    **ao-fan Shi, Yun-chao Su in Current Medical Science
    Article 01 June 2020
Did you find what you were looking for? Share feedback.